Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of Replenine-VF in Severe Haemophilia B
NCT02263456Phase 3Completed
- Sponsor
- Bio Products Laboratory
- Start
- Jul 1997
- Primary completion
- Sep 2001
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of coagulation factor IX human in Hemophilia B (HB), sponsored by Bio Products Laboratory. Started Jul 1997; status: completed.
02
Drugs
coagulation factor IX human
03
Conditions
Hemophilia B (HB)
Beyond the preview
Go deeper on NCT02263456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263456.